cefodizime has been researched along with Acute Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cocuzza, G; Zanussi, C | 1 |
| Valcke, Y; Van der Straeten, M | 1 |
| Kourilsky, O | 1 |
| Davies, BI; Geraedts, WH; Gubbelmans, HL; Maesen, FP; Meek, JC; van den Bergh, JJ | 1 |
3 trial(s) available for cefodizime and Acute Disease
| Article | Year |
|---|---|
Open, controlled, randomized study on the efficacy and safety of cefodizime single daily dose versus two daily doses and versus ceftriaxone single daily dose in patients with acute purulent bronchitis and acute purulent exacerbation of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefotaxime; Ceftriaxone; Cephalosporins; Chronic Disease; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male | 1995 |
Efficacy and tolerance of cefodizime in the treatment of acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Female; Humans; Male; Middle Aged; Pyelonephritis | 1990 |
Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bronchitis; Cefotaxime; Chronic Disease; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Sputum | 1990 |
1 other study(ies) available for cefodizime and Acute Disease
| Article | Year |
|---|---|
Changes in lymphocyte subpopulations in patients treated with cefodizime for acute lower respiratory tract infections.
Topics: Acute Disease; CD4-CD8 Ratio; Cefotaxime; Female; Humans; Immunologic Factors; Male; Respiratory Tract Infections; T-Lymphocyte Subsets | 1992 |